|
[1] OMATA M,CHENG AL,KOKUDO N,et al. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma:A 2017 update[J]. Hepatol Int,2017,11(4):317-370.
|
|
[2] YAN H,LU XL,GAO YQ,et al. Epidemiological investigation of fatty liver disease in Northwest China[J]. Chin J Hepatol,2015,23(8):622-627.(in Chinese)延华，鲁晓岚，高艳琼，等．西北地区脂肪性肝病的流行病学调查研究[J]．中华肝脏病杂志，2015,23(8):622-627.
|
|
[3] LI S,TAN HY,WANG N,et al. The Role of Oxidative Stress and Antioxidants in Liver Diseases[J]. Int J Mol Sci,2015,16(11):26087-26124.
|
|
[4] MCCLAIN C,VATSALYA V,CAVE M. Role of zinc in the development/progression of alcoholic liver disease[J]. Curr Treat Options Gastroenterol,2017,15(2):285-295.
|
|
[5] AJAKAIYE M,JACOB A,WU R,et al. Alcohol and hepatocyteKupffer cell interaction(review)[J]. Mol Med Rep,2011,4(4):597-602.
|
|
[6] ZHU H,JIA Z,MISRA H,et al. Oxidative stress and redox signaling mechanisms of alcoholic liver disease:Updated experimental and clinical evidence[J]. J Dig Dis,2012,13(3):133-142.
|
|
[7] CENI E,MELLO T,GALLI A. Pathogenesis of alcoholic liver disease:Role of oxidative metabolism[J]. World J Gastroenterol,2014,20(47):17756-17772.
|
|
[8] TESCHKE R. Alcoholic steatohepatitis(ASH)and alcoholic hepatitis(AH):Cascade of events,clinical aspects,and pharmacotherapy options[J]. Expert Opin Pharmacother,2018,19(8):779-793.
|
|
[9] KALYANARAMAN B. Teaching the basics of redox biology to medical and graduate students:Oxidants,antioxidants and disease mechanisms[J]. Redox Biol,2013,1:244-257.
|
|
[10] TANG Y,LI Y,YU H,et al. Quercetin attenuates chronic ethanol hepatotoxicity:Implication of “free”iron uptake and release[J]. Food Chem Toxicol,2014,67:131-138.
|
|
[11] DI LUZIO NR. A mechanism of the acute ethanol-induced fatty liver and the modification of liver injury by antioxidants[J]. Am J Pharm Sci Support Public Health,1966,15(1 Pt1):50-63.
|
|
[12] GALICIA-MORENO M,GUTIRREZ-REYES G. The role of oxidative stress in the development of alcoholic liver disease[J]. Rev Gastroenterol Mex,2014,79(2):135-144.
|
|
[13] PROCTOR LM. The Human Microbiome Project in 2011 and beyond[J]. Cell Host Microbe,2011,10(4):287-291.
|
|
[14] YAN AW,FOUTS DE,BRANDL J,et al. Enteric dysbiosis associated with a mouse model of alcoholic liver disease[J].Hepatology,2011,53(1):96-105.
|
|
[15] BJRKHAUG ST,AANES H,NEUPANE SP,et al. Characterization of gut microbiota composition and functions in patients with chronic alcohol overconsumption[J]. Gut Microbes,2019,10(6):663-675.
|
|
[16] MUTLU EA,GILLEVET PM,RANGWALA H,et al. Colonic microbiome is altered in alcoholism[J]. Am J Physiol Gastrointest Liver Physiol,2012,302(9):g966-g978.
|
|
[17] XIE G,ZHONG W,ZHENG X,et al. Chronic ethanol consumption alters mammalian gastrointestinal content metabolites[J]. J Proteome Res,2013,12(7):3297-3306.
|
|
[18] SCHNABL B,BRENNER DA. Interactions between the intestinal microbiome and liver diseases[J]. Gastroenterology,2014,146(6):1513-1524.
|
|
[19] LECLERCQ S,de SAEGER C,DELZENNE N,et al. Role of inflammatory pathways,blood mononuclear cells,and gutderived bacterial products in alcohol dependence[J]. Biol Psychiatry,2014,76(9):725-733.
|
|
[20] YANG AM,INAMINE T,HOCHRATH K,et al. Intestinal fungi contribute to development of alcoholic liver disease[J]. J Clin Invest,2017,127(7):2829-2841.
|
|
[21] STICKEL F,DATZ C,HAMPE J,et al. Pathophysiology and management of alcoholic liver disease:Update 2016[J]. Gut Liver,2017,11(2):173-188.
|
|
[22] DODGE NC,JACOBSON JL,JACOBSON SW. Protective effects of the alcohol dehydrogenase-ADH1B*3 allele on attention and behavior problems in adolescents exposed to alcohol during pregnancy[J]. Neurotoxicol Teratol,2014,41:43-50.
|
|
[23] AGRAWAL A,BIERUT LJ. Identifying genetic variation for alcohol dependence[J]. Alcohol Res,2012,34(3):274-281.
|
|
[24] KOLLA BP,SCHNEEKLOTH TD,BIERNACKA J,et al. PNPLA3association with alcoholic liver disease in a cohort of heavy drinkers[J]. Alcohol Alcohol,2018,53(4):357-360.
|
|
[25] ZHANG Y,GUO T,YANG F,et al. Single-nucleotide rs738409polymorphisms in the PNPLA3 gene are strongly associated with alcoholic liver disease in Han Chinese males[J]. Hepatol Int,2018,12(5):429-437.
|
|
[26] FRIEDRICH K,WANNHOFF A,KATTNER S,et al. PNPLA3 in end-stage liver disease:Alcohol consumption,hepatocellular carcinoma development,and transplantation-free survival[J]. J Gastroenterol Hepatol,2014,29(7):1477-1484.
|
|
[27] DING WX,LI M,CHEN X,et al. Autophagy reduces acute ethanol-induced hepatotoxicity and steatosis in mice[J].Gastroenterology,2010,139(5):1740-1752.
|
|
[28] WILLIAMS JA,DING WX. A mechanistic review of mitophagy and its role in protection against alcoholic liver disease[J]. Biomolecules,2015,5(4):2619-2642.
|
|
[29] DING WX. Role of autophagy in liver physiology and pathophysiology[J]. World J Biol Chem,2010,1(1):3-12.
|
|
[30] LIN CW,ZHANG H,LI M,et al. Pharmacological promotion of autophagy alleviates steatosis and injury in alcoholic and non-alcoholic fatty liver conditions in mice[J]. J Hepatol,2013,58(5):993-999.
|
|
[31] HARADA M. Autophagy is involved in the elimination of intracellular inclusions,Mallory-Denk bodies,in hepatocytes[J].Med Mol Morphol,2010,43(1):13-18.
|
|
[32] THOMES PG,TRAMBLY CS,FOX HS,et al. Acute and chronic ethanol administration differentially modulate hepatic autophagy and transcription factor EB[J]. Alcohol Clin Exp Res,2015,39(12):2354-2363.
|
|
[33] CHAO X,WANG S,ZHAO K,et al. Impaired TFEB-mediated lysosome biogenesis and autophagy promote chronic ethanol-induced liver injury and steatosis in mice[J]. Gastroenterology,2018,155(3):865-879.
|
|
[34] SCHULZE RJ,RASINENI K,WELLER SG,et al. Ethanol exposure inhibits hepatocyte lipophagy by inactivating the small guanosine triphosphatase Rab7[J]. Hepatol Commun,2017,1(2):140-152.
|
|
[35] RASINENI K,DONOHUE TM Jr,THOMES PG,et al. Ethanol-induced steatosis involves impairment of lipophagy,associated with reduced Dynamin2 activity[J]. Hepatol Commun,2017,1(6):501-512.
|
|
[36] BLAYA D,COLL M,RODRIGO-TORRES D,et al. Integrative microRNA profiling in alcoholic hepatitis reveals a role for microRNA-182 in liver injury and inflammation[J]. Gut,2016,65(9):1535-1545.
|
|
[37] BALA S,CSAK T,SAHA B,et al. The pro-inflammatory effects of miR-155 promote liver fibrosis and alcohol-induced steatohepatitis[J]. J Hepatol,2016,64(6):1378-1387.
|
|
[38] SATISHCHANDRAN A,AMBADE A,RAO S,et al. MicroRNA122,regulated by GRLH2,protects livers of mice and patients from ethanol-induced liver disease[J]. Gastroenterology,2018,154(1):238-252.
|
|
[39] LI M,HE Y,ZHOU Z,et al. MicroRNA-223 ameliorates alcoholic liver injury by inhibiting the IL-6-p47phox-oxidative stress pathway in neutrophils[J]. Gut,2017,66(4):705-715.
|
|
[40] WANG S,DING WX. A small RNA in neutrophils protects against acute-on-chronic alcoholic liver injury[J]. Gut,2017,66(4):565-566.
|
|
[41] ZHAO YX,SUN YY,HUANG AL,et al. MicroRNA-200a induces apoptosis by targeting ZEB2 in alcoholic liver disease[J]. Cell Cycle,2018,17(2):250-262.
|
|
[42] LI HH,TYBURSKI JB,WANG YW,et al. Modulation of fatty acid and bile acid metabolism by peroxisome proliferator-activated receptorαprotects against alcoholic liver disease[J].Alcohol Clin Exp Res,2014,38(6):1520-1531.
|
|
[43] HUANG CK,YU T,de la MONTE SM,et al. Restoration of Wnt/β-catenin signaling attenuates alcoholic liver disease progression in a rat model[J]. J Hepatol,2015,63(1):191-198.
|
|
[44] SEITZ HK,BATALLER R,CORTEZ-PINTO H,et al. Alcoholic liver disease[J]. Nat Rev Dis Primers,2018,4(1):16.
|
|
[45] OSNA NA,DONOHUE TM Jr,KHARBANDA KK. Alcoholic liver disease:Pathogenesis and current management[J]. Alcohol Res,2017,38(2):147-161.
|
DownLoad: